Immunohistochemical staining revealed that the expression levels of CD-31 and PTPN12 in tumor tissues were significantly increased in the group treated with sEVs, whereas these levels were significantly decreased in the group treated with the miR-494-3p inhibitor (Fig. 8G). Here, PTPN12 is linked to neoplasm.